Exelixis
EXEL
#1800
Rank
HK$86.00 B
Marketcap
HK$319.49
Share price
-1.91%
Change (1 day)
16.65%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company